Applications of 2-Amino-4-Trifluoromethyl-Thiazole-5-Carboxylic Acid Ethyl Ester in Industrial Manufacturing

As a direct manufacturer of 2-Amino-4-Trifluoromethyl-Thiazole-5-Carboxylic Acid Ethyl Ester, we supply this advanced intermediate to several focused downstream sectors. The molecular structure and functional groups enable precise transformations in pharmaceutical synthesis, crop protection production, veterinary active ingredient preparation, and fine chemical intermediates manufacture. Below, we detail key application scenarios according to real-world industrial practices.

1. Pharmaceutical Intermediate Synthesis for Anti-infective APIs

Pharmaceutical manufacturers use this thiazole ester as a critical building block for constructing anti-infective active pharmaceutical ingredients, notably within the cephalosporin and thiazole-derived antibiotic categories. The fluorinated thiazole ring delivers essential pharmacophore characteristics, supporting medicinal chemists in optimizing molecular scaffolds during late-stage synthesis. Its integration into API production requires close control over impurities and residual solvents, ensuring batch consistency and patient safety for regulated pharmaceutical markets.

Industry compliance standards

• ICH Q7A Good Manufacturing Practice for Active Pharmaceutical Ingredients
• Ph. Eur. (European Pharmacopoeia) monographs for intermediates and APIs
• US FDA 21 CFR Part 210/211 (GMP)
• China Pharmacopoeia standards for chemical raw materials

Typical usage ratio

• Ranges from 0.8 to 1.2 molar equivalents, adjusted according to the target API conversion yield and stoichiometry requirements in multi-step synthesis

Downstream process integration

• Introduced during core ring assembly or side-chain modification steps within the chemical synthesis route of anti-infective APIs, often under anhydrous and inert conditions to minimize degradation

Final product types

• Cephalosporin-type active pharmaceutical ingredients (APIs)
• Thiazole-based penicillin derivatives
• Generic and originator anti-infective tablets, capsules, and injectables (following downstream formulation)

2. Plant Protection Active Ingredient Synthesis

Agrochemical formulators utilize this fluorinated thiazole ester to construct specific herbicide, fungicide, and insecticide actives, where its trifluoromethyl group drives bioactivity and persistency. The molecule serves as an essential intermediate in the synthesis of systemically acting agents for cereal and specialty crop protection, demanding rigorous traceability and contaminant control to comply with international standards on residue limits and environmental safety.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• European Union Regulation (EC) No 1107/2009 on PPPs
• OECD guidelines on chemical product characterization
• ISO 9001:2015 quality management for chemical synthesis

Typical usage ratio

• 0.4%–2.0% by mass in reaction mixtures, depending on the target active’s required loading and performance data from prior scale-up batches

Downstream process integration

• Charged at the initial nucleophilic substitution or cyclization step during active ingredient synthesis; subsequent isolation and purification for technical-grade product proceeds before formulation into final agrochemicals

Final product types

• Triazole- and thiazole-based fungicide concentrates
• Selective herbicide technical concentrates
• Ready-to-apply aqueous or emulsifiable crop protection products

3. Veterinary Drug Active Intermediate

Veterinary pharmaceutical producers incorporate this compound during the route design for anti-parasitic and anti-bacterial agents, benefiting from its thiazole motif which enhances pharmacokinetic properties in animals. The raw material enters pilot and full-scale production campaigns where GMP and trace impurity thresholds align with animal health regulations. The substance’s ethyl ester moiety enables targeted reactivity during intermediate coupling stages, minimizing side reactions in veterinary molecule assembly.

Industry compliance standards

• VICH GL3 GMP Guidance for Active Pharmaceutical Ingredients for Veterinary Medicines
• European Medicines Agency (EMA) Guidance for Veterinary Medicinal Products
• Regulations of the Ministry of Agriculture and Rural Affairs of China on veterinary drugs
• ISO 22716 (Cosmetics GMP, where relevant for topical veterinary formulations)

Typical usage ratio

• 1.0 to 1.5 molar equivalents based on the coupling partner and desired batch yield across varying animal drug formulations

Downstream process integration

• Mixed with amine or acid co-reactants during the intermediate stage of veterinary drug synthesis, usually under monitored temperature and solvent conditions

Final product types

• Veterinary antibiotics (injectables and oral dosages)
• Anti-parasitic API intermediates
• Suppository and topical veterinary ointments derived from thiazole actives

4. Specialty Fine Chemical Intermediate for Performance Materials

Fine chemical companies employ this raw material in the synthesis of performance functional materials requiring fluoroalkyl and thiazole building blocks. Its unique structure supports the creation of specialty additives used in electronics, polymer modification, and functional surface coatings. Process requirements emphasize batch-to-batch reproducibility and the avoidance of metal or halide contamination to assure downstream product reliability.

Industry compliance standards

• REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) compliance for polymers and specialty chemicals in the EU markets
• ISO 9001:2015 for quality control in fine chemical manufacturing
• Global automotive OEM materials standards (such as GMW, VW, or ISO standards for chemical additives)
• RoHS (Restriction of Hazardous Substances) for electronics-related components

Typical usage ratio

• 0.1%–1.2% by weight in precursor formulations, depending on target compound design and end-use performance data requirements

Downstream process integration

• Fed into functionalization or condensation steps in fine chemical synthesis; handled under inert gas and strict QC monitoring for purity and contaminant profile

Final product types

• Advanced polymer additives with thiazole–fluorine motifs
• Organic electronic materials
• Performance coatings and surface-modifier intermediates